Skip to content

Ágnes K. Mike

3 papers in the library · 51 citations · publishing 2011-2013

Papers

Sort Most recent Most cited

Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile.

Toxicology and Applied Pharmacology December 1, 2013 Xaver Koenig, Michael Kovar, Lena Rubi et al. 46 citations

The plant alkaloid ibogaine has promising anti-addictive properties. Albeit not licensed as a therapeutic drug, and despite hints that ibogaine may perturb the heart rhythm, this alkaloid is used to treat drug addicts. We have recently reported that ibogaine inhibits human ERG (hERG) potassium channels at concentrations similar to the drugs affinity for several of its known brain targets....

The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential

BMC Pharmacology and Toxicology September 1, 2012 Xaver Koenig, Michael Kovar, Lena Rubi et al.

The plant alkaloid ibogaine has shown promising anti-addictive properties in animals and humans. Although not licensed as a therapeutic drug, and despite evidence that ibogaine may disturb the rhythm of the heart, this alkaloid is used as an anti-addiction drug in alternative medicine. We have recently reported that therapeutic concentrations of ibogaine inhibit human ERG (hERG) potassium...

The anti-addictive drug ibogaine modulates voltage-gated ion channels and may trigger cardiac arrhythmias

BMC Pharmacology September 5, 2011 Michael Kovar, Xaver Koenig, Ágnes K. Mike et al. 5 citations

Background Ibogaine is an alkaloid derived from the African shrub Tabernanthe iboga. Psychoactive properties of ibogaine have been known for decades, but more recently the drug has received much attention because of its promising “anti-addictive” actions. Thus, ibogaine and its derivatives are being studied as potential treatment for opioid and stimulant abuse, as well as for alcoholism and...